tanshinone ii a has been researched along with scutellarein in 3 studies
| Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (scutellarein) | Trials (scutellarein) | Recent Studies (post-2010) (scutellarein) |
|---|---|---|---|---|---|
| 61 | 0 | 41 | 139 | 1 | 97 |
| Protein | Taxonomy | tanshinone ii a (IC50) | scutellarein (IC50) |
|---|---|---|---|
| Histone-lysine N-methyltransferase NSD2 | Homo sapiens (human) | 2.65 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 3.02 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.02 | |
| Alpha-amylase 1A | Homo sapiens (human) | 9.64 | |
| G protein-coupled receptor kinase 6 | Homo sapiens (human) | 6.61 | |
| Histone-lysine N-methyltransferase 2A | Homo sapiens (human) | 2.92 | |
| Receptor-type tyrosine-protein phosphatase S | Homo sapiens (human) | 0.6 | |
| Histone-lysine N-methyltransferase SETD7 | Homo sapiens (human) | 1.96 | |
| Histone-lysine N-methyltransferase EZH1 | Homo sapiens (human) | 8.77 | |
| Aurora kinase B | Homo sapiens (human) | 3.85 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
3 other study(ies) available for tanshinone ii a and scutellarein
| Article | Year |
|---|---|
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |